JP2009540278A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540278A5
JP2009540278A5 JP2009513608A JP2009513608A JP2009540278A5 JP 2009540278 A5 JP2009540278 A5 JP 2009540278A5 JP 2009513608 A JP2009513608 A JP 2009513608A JP 2009513608 A JP2009513608 A JP 2009513608A JP 2009540278 A5 JP2009540278 A5 JP 2009540278A5
Authority
JP
Japan
Prior art keywords
annexin
antibody
cancer
human
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009513608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540278A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/005134 external-priority patent/WO2007141043A2/en
Publication of JP2009540278A publication Critical patent/JP2009540278A/ja
Publication of JP2009540278A5 publication Critical patent/JP2009540278A5/ja
Ceased legal-status Critical Current

Links

JP2009513608A 2006-06-09 2007-06-11 前立腺癌腫の検出のためのモノクローナル抗アネキシンa3抗体 Ceased JP2009540278A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US85948906P 2006-11-17 2006-11-17
PCT/EP2007/005134 WO2007141043A2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma

Publications (2)

Publication Number Publication Date
JP2009540278A JP2009540278A (ja) 2009-11-19
JP2009540278A5 true JP2009540278A5 (enExample) 2010-07-29

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009513608A Ceased JP2009540278A (ja) 2006-06-09 2007-06-11 前立腺癌腫の検出のためのモノクローナル抗アネキシンa3抗体

Country Status (13)

Country Link
US (1) US8012697B2 (enExample)
EP (1) EP2024748B1 (enExample)
JP (1) JP2009540278A (enExample)
KR (1) KR20090023372A (enExample)
AU (1) AU2007256377B2 (enExample)
CA (1) CA2654330A1 (enExample)
DE (1) DE07725949T1 (enExample)
DK (1) DK2024748T3 (enExample)
ES (1) ES2396730T3 (enExample)
PL (1) PL2024748T3 (enExample)
PT (1) PT2024748E (enExample)
RU (1) RU2467335C2 (enExample)
WO (1) WO2007141043A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
WO2010034825A2 (en) * 2008-09-26 2010-04-01 Proteosys Ag Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) * 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) * 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
US9487831B2 (en) * 2013-09-12 2016-11-08 Versitech Limited Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
US20030108963A1 (en) 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
PL1720611T3 (pl) 2004-02-16 2010-09-30 Proteosys Ag Marker diagnostyczny dla raka
EP1724586A3 (en) 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment

Similar Documents

Publication Publication Date Title
US20230026100A1 (en) Anti-muc16 antibodies and uses thereof
CA2798778C (en) Anti-human trop-2 antibody having anti-tumor activity in vivo
EP2386577A3 (en) Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
JP2009540278A5 (enExample)
EA201001874A1 (ru) Способ диагностики злокачественных новообразований, экспрессирующих рецептор her2 или его укороченные варианты
HRP20171292T1 (hr) Polipeptidi i konjugati klorotoksina i njihove uporabe
AR075798A1 (es) Proteinas de union a il-17 (interleuquina 17)
JP2010533498A5 (enExample)
MX2009005743A (es) Nuevos anticuerpos monoclonales de globulomero anti-ab selectivos del conformero ab.
JP2009297037A5 (enExample)
JP2013503205A5 (enExample)
JP2012523848A5 (enExample)
JP2009517057A5 (enExample)
NZ597067A (en) Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
JP2010523592A5 (enExample)
IL212056A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
CA2786479A1 (en) Methods for treating pancreatic cancer
JP2009529497A5 (enExample)
JP2021500916A5 (enExample)
CA2793647A1 (en) Prophylaxis of colorectal and gastrointestinal cancer
JP2014515600A5 (enExample)
CN102180969B (zh) 抗肝癌活性单克隆抗体及其应用
NZ597611A (en) Anti notch-1 antibodies
WO2008025964A3 (en) Antibodies to an epitope of agr2. assays and hybridomas